Find partners
Health and Explainable AI Podcast

Health and Explainable AI Podcast

Hosted by Pitt HexAI Lab and the Computational Pathology and AI Center of Excellence

TechnologyInterviews guests

Episodes

45

Latest episode

Oct 2026

Language

EN-US

About the show

The Health and Explainable AI podcast is a collaborative initiative between the Health and Explainable AI (HexAI) Research Lab in the Department of Health Information Management at the School of Health and Rehabilitation Sciences, and the Computational Pathology and AI Center of Excellence (CPACE), at the University of Pittsburgh School of Medicine. Led by Ahmad P. Tafti, Hooman Rashidi and Liron Pantanowitz, the podcast explores the transformative integration of responsible and explainable artificial intelligence into health informatics, clinical decision-making, and computational medicine.

Listen to episodes

45 recent
October 18, 2026Episode 4535 min

Dr. Francesco Lescai on Computational Genomics, the SIEVE Framework and Explainable AI for Discovery

In this episode of the University of Pittsburgh’s Health and Explainable AI Podcast, host Jordan Gass-Pooré speaks with Francesco Lescai, PhD, Associate Professor of Bioinformatics and Head of the Computational Genomics Laboratory at the University of Pavia. Reflecting on his career transition from wet-lab immunology to computational genomics, Francesco discusses his work, explainable AI and the necessity of interdisciplinary training across computer science, genetics, and health informatics to solve complex human disease traits. The conversation focuses on his lab's SIEVE framework (Sparse Interpretable Exome Variant Explainer), a deep learning framework that advances explainable AI by shifting the paradigm from post-hoc model auditing to using inherently interpretable architectures as active engines for biological discovery. For students and practitioners in explainable AI, his work offers practical insights into model development, demonstrating how training "null" baseline models ensures attributions reflect true biological signals over computational noise, how annotation-ablation protocols measure a model's reliance on raw genomic architecture versus pre-existing labels, and how capping GPU memory limits power consumption while actively measuring CO2 footprints to keep XAI sustainable. Francesco also highlights the necessity of making research openly available for external critique across disciplines to catch architectural blind spots and drive healthier, more collaborative science. Aligning with the mission of the University of Pittsburgh's Health and Explainable AI (HexAI) Research Laboratory, Francesco offers insights for students and computational researchers on navigating sparse clinical datasets, developing robust machine learning architectures for rare diseases, and advancing inter-institutional sample sharing networks. Reflecting core priorities of Pitt's Computational Pathology and AI Center of Excellence (CPACE), the discussion illustrates how explainable machine learning and sensor-driven molecular profiling advance the frontiers of computational pathology and precision diagnostics. He closes the episode by encouraging students to build transparent, interpretable models for genomic medicine Host: Jordan Gass-Pooré | Producer: Brent Phillips | Guest: Francesco Lescai, PhD (Associate Professor of Bioinformatics & Head of Computational Genomics Laboratory, University of Pavia) Topics: Computational Genomics | Explainable AI (XAI) | SIEVE Framework | Variant Interactions | Data Governance & Privacy | Sustainable Computing (CO2 Footprint) Institutions: University of Pittsburgh | University of Pavia | Norwegian University of Science and Technology (NTNU) Links: [YouTube] https://www.youtube.com/watch?v=MxQ3LgrPxZs&t=27s [Pitt HexAI Lab] https://pitthexai.github.io/ [SIEVE Project] https://lescailab.github.io/sieve-project/

October 18, 2026Episode 4422 min

James Grana and Andrew Fogner: The Payer Perspective on Explainable AI and Population Health

In this episode of the University of Pittsburgh’s Health and Explainable AI (HexAI) Podcast, host Jordan Gass-Pooré speaks with James Grana, Vice President of Value-Based Care Programs, Innovations, and Contracting with BlueCross BlueShield of South Carolina, and his colleague Andrew Fogner, Epidemiologist and Manager of Data Science and Strategic Analytics. Exploring a new vantage point for the podcast, the conversation examines the integration of artificial intelligence and advanced analytics into healthcare from the perspective of health insurance providers. James and Andrew reflect on the unique position that payers occupy within the healthcare ecosystem, highlighting how health insurance providers leverage longitudinal, population-level data across multiple health systems and care settings to evaluate total cost of care, patient outcomes, and health equity. Bridging operational data science with clinical decision support, the discussion outlines the distinct roles of predictive models in risk stratification and generative AI in accelerating administrative workflows, documentation and care management outreach. The guests address the growing "arms race" between payers and providers regarding AI adoption for coding, approvals and contract review, while emphasizing the imperative of maintaining "humans in the loop" to mitigate hallucination risks and ensure trust. Crucially, the dialogue connects explainable AI directly to value-based care, illustrating how transparent and interpretable models build clinician confidence, support proactive population health interventions and ensure AI tools drive meaningful health improvements rather than fee-for-service volume. Aligning with the mission of Pitt’s HexAI Research Laboratory, James and Andrew offer insights for students and computational researchers on addressing sparse data, establishing AI governance frameworks and evaluating real-world model impact. Reflecting core priorities of Pitt's Computational Pathology and AI Center of Excellence (CPACE), the discussion illustrates how explainable machine learning and sensor-driven molecular profiling advance the frontiers of computational pathology and precision diagnostics. They close the episode by inviting academic research labs to partner with payers in establishing independent model evaluations, acting as a trusted "Consumer Reports for AI” and developing an ethical moral compass to prevent fraud, waste, and abuse in AI-powered healthcare. Host: Jordan Gass-Pooré | Producer: Brent Phillips | Guests: James Grana (VP of Value-Based Care Programs, Innovations & Contracting, Blue Cross Blue Shield) & Andrew Fogner (Epidemiologist & Manager of Data Science & Strategic Analytics, Blue Cross Blue Shield) Topics: Health Insurance Analytics | Value-Based Care | Explainable AI (XAI) | Population Health Management | AI Governance & Ethics | Predictive vs. Generative AI Institutions: University of Pittsburgh | Blue Cross Blue Shield of South Carolina Links: [YouTube] https://www.youtube.com/watch?v=etPqZQw977E [Pitt HexAI Lab] https://hexai.pitt.edu

October 18, 2026Episode 4334 min

Dr. Daniel Heller on Cancer Nanomedicine, Optical Nanosensors, and Explainable AI in Early Diagnostics

In this episode of the University of Pittsburgh’s Health and Explainable AI (HexAI) Podcast, host Jordan Gass-Pooré speaks with Daniel Heller, PhD, Head of the Cancer Nanomedicine Laboratory at Memorial Sloan Kettering Cancer Center and Professor at Weill Cornell Medicine. Anchoring the discussion around the convergence of computational medicine, nanotechnologies, and explainable machine learning, Daniel shares his journey from early interest in carbon nanotubes at Rice University to leading cutting-edge research in cancer diagnostics, and then goes on to provide listeners with an overview on the scope of biosensor technology and variety of internal and external biosensors being studied and applied today, ranging from micro-scale pill cameras and implantable devices down to optical nanosensors operating at one hundred-thousandth the width of a human hair. Bridging the gap between material chemistry and artificial intelligence, Daniel details how his lab utilizes arrays of surface-modified carbon nanotubes to capture biological data. Drawing an analogy to the human olfactory system, he explains how these sensors forgo single-biomarker recognition in favor of creating multi-signal optical "fingerprints" from blood plasma, which are then evaluated by supervised machine learning models to detect early-stage ovarian cancer and differentiate brain tumor subtypes for example. Crucially, the conversation highlights how explainable AI techniques, such as feature importance analyses, SHAP, and LIME, are inverted to drive scientific discovery. By identifying which nanosensors contribute most to the model’s diagnostic decisions, researchers can wash off bound proteins to isolate rare, disease-specific biomarkers and map out the broader systemic "tumor ecosystem". Aligning with the mission of the University of Pittsburgh's HexAI Research Laboratory, Daniel offers insights for students and computational researchers on navigating sparse clinical datasets, developing robust machine learning architectures for rare diseases, and advancing interinstitutional sample-sharing networks. Reflecting core priorities of Pitt's Computational Pathology and AI Center of Excellence (CPACE), the discussion illustrates how explainable machine learning and sensor-driven molecular profiling advance the frontiers of computational pathology and precision diagnostics. He closes the episode with a call to action for students with interdisciplinary backgrounds across programming, chemistry, and clinical biology to explore careers at the intersection of nanotechnology and explainable AI. Host: Jordan Gass-Pooré | Producer: Brent Phillips | Guest: Daniel Heller, PhD (Head of Cancer Nanomedicine, Memorial Sloan Kettering Cancer Center & Weill Cornell Medicine) Topics: Cancer Nanomedicine | Explainable AI (XAI) | Nanosensors | Feature Importance Analysis | Biomarker Discovery | Micro-Robotics Institutions: University of Pittsburgh | Memorial Sloan Kettering Cancer Center | Weill Cornell Medicine Links: [YouTube] https://www.youtube.com/watch?v=idE_5qxqvb4&t=5s [Guest Profile] https://www.mskcc.org/research/ski/labs/daniel-heller [Pitt HexAI Lab] https://pitthexai.github.io/

July 18, 2026Episode 4248 min

Sean McGunigal on Epic Software’s Role in Advancing the Frontier of AI in Healthcare

In this special episode, HexAI producer Brent Phillips steps behind the microphone to speak with Sean McGunigal, Epic Software’s Software Development Lead for AI Research and Development. Drawing from his own daily experience navigating healthcare information management systems at a hospital, Brent guides a technical conversation on the immense role that enterprise software architectures like Epic play in orchestrating, optimizing, and embedding artificial intelligence directly into clinical workflows across global health systems. Bridging the gap between frontier software engineering and clinical realities, Sean and Brent discuss Epic's AI development pipeline while anchoring the conversation around Epic’s technical vision where utility, explainability, and trust are paramount. Sean details how Epic’s proprietary ambient AI framework, Chart with Art, seamlessly ingests and parses acoustic conversational data to generate structured documentation, effectively alleviating cognitive burden and clinical friction so medical professionals can prioritize hands-on patient care. Sean emphasizes that to achieve user adoption, Epic's generative summaries are rigidly tied to programmatic data lineage and granular citations, forcing black-box models to prove their clinical outputs. Aligning with the mission of the University of Pittsburgh’s Health and Explainable AI Research Laboratory and Pitt’s Computational Pathology and AI Center of Excellence (CPACE), the episode highlights Epic’s commitment to helping advance and democratize ethical and responsible AI engineering through open-source frameworks and massive data initiatives. Sean points to Nebula, Epic’s cloud-native platform deployed in Microsoft Azure, which provides a high-throughput, horizontally scalable infrastructure allowing health networks to securely deploy LLMs. Furthermore, he underscores Epic's breakthroughs with Cosmos, their multi-institution de-identified dataset, and Curiosity, Epic's custom-trained Medical Language Model designed to predict patient clinical events using autoregressive, next-token intelligence. By exploring the orchestration of complex agentic AI workflows, runtime evaluation harnesses, and cross-platform communication protocols, Sean closes the episode with a call to action for researchers to get involved and work more closely around safely advancing the frontiers of computational medicine.

June 3, 2026Episode 4130 min

Beyond the Pixels: Dr. Bradley Erickson from the Mayo AI Lab on Medical Imaging and Radiology

Dr. Bradley Erickson, Director of the Mayo AI Lab, speaks with HexAI podcast host, Jordan Gass-Pooré in advance of the University of Pittsburgh’s annual AI Summer School program in Medical Imaging Informatics organized by Pitt's Health and Explainable AI Research Lab (HexAI) and the Computational Pathology and AI center of Excellence (CPACE). The episode simulates two different professional vantage point scenarios to help students visualize the vast, multi-dimensional landscape of artificial intelligence in healthcare and radiology. The first half of the episode drops students directly into the vantage point of an AI expert attending a technical conference, where medical imaging informatics are being contrasted with everyday computer vision. Dr. Erickson explains how medical data often extends into multiple dimensions by incorporating complex spatial matrices and tissue properties like T1 and T2 tracking on MRIs, far surpassing standard 2D photographic pixels. He highlights why generic consumer AI tools like simple heat maps or saliency maps fall short of establishing clinical trust; while they can successfully point to where a brain tumor is, they completely fail to explain what that tumor is or why it is changing texture. Furthermore, Dr. Erickson discusses the profound challenge of "ground truth" uncertainty in medicine, explaining that training predictive algorithms is incredibly difficult because definitive biological labels are frequently masked by biological reactions or a lack of definitive longitudinal data. The second half of the podcast episode places students into the role and vantage point of a hospital administrator, exposing students to the active economic and structural deliberations currently playing out in modern hospital boardrooms. Dr. Erickson underscores the considerations and financial constraints that hospitals contend with and explains that while new narrowly focused diagnostic AI tools are attractive, the most immediate return on investment for hospitals often comes from practical, language-based text summarization and ambient patient recording systems. Crucially, this administrative perspective teaches students that the health industry desperately needs supportive roles beyond traditional doctors and researchers, such as AI project managers, integration specialists, and governance officers who can oversee model confidence and decide exactly when to adapt AI solutions or pull failing applications or algorithms back. Dr. Erickson emphasizes that entering this revolutionary field requires a willingness to learn through iteration, push back on assumptions, and manage the critical intersections of technology, safety, and human care. Through an open exploration of technical hurdles and administrative realities, the episode provides a rich conceptual primer for AI Summer School participants designed to cultivate critical thinking informing views on AI in medical imaging, hands-on project development and coding.

May 14, 2026Episode 4028 min

Innovating Precision Medicine with Dr. Freddy Nguyen

Dr. Freddy Nguyen, a physician-scientist-entrepreneur and Director of MIT’s Catalyst Scholars Program, discusses his work at the frontier of translational research, diagnostics, precision medicine and healthcare innovation with Pit HexAI host Jordan Gass-Poore' and his involvement in co-founding Nine Diagnostics, a startup spun out of Memorial Sloan Kettering Cancer Center. Focusing on innovation in precision medicine, Dr. Nguyen traces his path through initiatives like MIT Hacking Medicine and the MIT Catalyst Scholars Program and his work helping teams identify and turn real clinical problems into projects designed to reach patients. Emphasizing patient‑first and science‑first approaches to innovation, Dr. Nguyen encourages students and collaborators to ask why things work the way they do and to build solutions that can move quickly from lab to clinic. That same mindset underpins Nine Diagnostics, which uses a high‑throughput nanosensor platform to generate molecular “fingerprints” of disease. Instead of tracking a few isolated biomarkers, these fingerprints capture complex patterns across thousands of molecules, reflecting both tumor biology and the broader physiological context of each patient. This shift from genomics alone to “functional precision medicine” enables clinicians and researchers to see what is happening in real time inside the body, monitor treatment response faster and tailor therapies more precisely to each patient. Touching on how AI and machine learning are making these technologies clinically useful, Dr. Nguyen discusses how advanced algorithms integrate multimodal data streams to discover patterns that would be impossible to detect by eye. These models not only improve sensitivity and specificity when predicting treatment response, but also support emerging “digital twin” computational representations of patient health that can be used to simulate and optimize care. At the same time, he emphasizes that more data is not automatically better, and that explainable AI in healthcare must focus on which signals truly matter for a specific clinical decision and how to close the loop between model outputs and underlying biology. For students and early‑career researchers, Dr. Nguyen shares practical guidance on getting involved in leveraging AI to advance precision medicine and designing research with translation in mind from day one so that innovations reach patients faster, rather than staying trapped in academic silos.

April 7, 2026Episode 3932 min

George Demiris on Proactive Healthcare and The Future of AI in Nursing and Aging

George Demiris, Associate Dean for Research and Innovation at the University of Pennsylvania School of Nursing and a “Penn Integrates Knowledge University Professor” discusses the transformative integration of responsible and explainable artificial intelligence into nursing, elder care, and hospice settings with Pit HexAI host Jordan Gass-Pooré. The University of Pennsylvania School of Nursing is actively integrating emerging technologies into its curriculum, research, and clinical practice to enhance person-centered care, ensuring that technological advancements support rather than replace human connection, with the Penn Artificial Intelligence and Technology (PennAITech) Collaboratory for Healthy Aging playing a central role in bringing together interdisciplinary experts to address the technical and ethical challenges of integrating AI into the aging process. Discussing his work focusing on information technology's role in the healthcare of older adults, specifically through smart home solutions and passive sensing systems that support aging in place, George advocates for a shift from reactive to proactive care, using sensors for example to detect subtle behavioral changes before adverse events like falls occur. However he argues that technology must remain a "decision aid" rather than a final decision-maker, advocating for "self-reflective AI" that explains its reasoning to clinicians. This approach preserves the "moral agency" of nurses, who act as vital patient advocates ensuring AI tools are introduced ethically and reflect the diverse preferences of those they serve. Looking ahead, the conversation stresses the need for fluid collaboration between academia and industry to keep pace with rapid innovation. George envisions a holistic future for AI that prioritizes human dignity and autonomy, utilizing generative tools to adapt complex medical information to the specific literacy and language needs of patients and their caregivers.

March 18, 2026Episode 3837 min

Martin Raison CTO of Nabla on Architecting the Agentic AI Era in Healthcare

Martin Raison, Co-founder and CTO of Nabla speaks with Pitt HexAI host Jordan Gass-Pooré about Nabla’s central role in architecting the agentic AI era in healthcare. Martin details Nabla’s evolution from a specialized ambient scribing tool into a comprehensive "Adaptive Agentic Platform". They discuss the significant challenges involved in making it possible for AI agents to perform complex clinical tasks and how Nabla has been thrust into tackling a labyrinth of structural and data hurdles. These range from the integration of fragmented, unstructured patient charts and hospital guidelines to the complex technicalities of agent discoverability, interoperability, and the establishment of standardized accountability frameworks. The interview highlights a significant shift in Nabla's technical strategy: moving from probabilistic Large Language Models (LLMs) toward world models. Raison explains that while LLMs are effective at generating text, they lack a fundamental understanding of cause-and-effect and the ability to simulate evolving environments. To address this, Nabla has entered an exclusive partnership with Advanced Machine Intelligence (AMI), a research lab co-founded by Yann LeCun. This collaboration provides Nabla with early access to world model technologies that can "imagine" different scenarios and simulate the consequences of actions, providing a more deterministic and auditable path for AI in high-stakes clinical settings. In discussing the technical foundations of computational health, Martin addresses the critical need for inference optimization to manage the millions of model executions required daily at scale. Furthermore, Martin envisions a fundamental shift in the paradigm of AI inference through the adoption of world models. He suggests that these architectures will blur the traditional boundary between training and inference by enabling continuous learning, where the model adjusts and evolves in real-time based on new data and clinician feedback, rather than being limited by the static context windows of current LLMs. Beyond the core technology, Martin and Jordan discuss the critical importance of explainability and interoperability in the "agentic web" of healthcare. They specifically highlight architectural initiatives like MIT’s Project NANDA, which focuses on the foundational layers of the agentic web, including critical elements like discoverability and authentication that go beyond the AI layer alone. Martin emphasizes that the sector must move toward standardized "Agent Fact Files" to ensure accountability and ease of governance as organizations begin to manage thousands of agents. He concludes by looking toward a future of "emergent intelligence," where the collaboration between multiple models creates sophisticated patterns that can eventually help clinicians improve their own professional practice over time.

February 7, 2026Episode 3728 min

Ekaterina Kldiashvili from the Tbilisi Medical Academy on Responsible Uses of AI, Medical Education and Inter-University Collaboration

Ekaterina Kldiashvili, Vice Rector for Research at Petre Shotadze Tbilisi Medical Academy, and Pitt’s HexAI podcast host, Jordan Gass-Pooré, discuss public health, the incorporation of AI into healthcare, responsible uses of AI, medical education and inter-university collaboration. Ekaterina and Jordan explore opportunities and concerns surrounding commercial AI applications, noting that while AI can improve healthcare efficiency, it must support clinical reasoning rather than replace it. They cover the Tbilisi Medical Academy’s work on responsible AI usage, particularly in educating providers and patients, demonstrating how AI-enhanced text and visuals can significantly improve patient understanding and follow-up rates. They also touch on challenges associated with the use of AI in non-English languages like Georgian and delve into advances in computational genomics and rapid molecular diagnostics. Looking ahead, they discuss the strengthening ties between the University of Pittsburgh and the Tbilisi Medical Academy through knowledge sharing and faculty training and broadly discuss inter-university collaboration and the idea of seeing students investigate how different cultures and communities trust and accept AI in healthcare settings.

December 18, 2025Episode 3630 min

Richard Bonneau from Genentech on Drug Discovery, Computational Sciences and Machine Learning

Richard Bonneau, Vice President of Machine Learning for Drug Discovery at Genentech and Roche, provides Pitt’s HexAI podcast host, Jordan Gass-Pooré, with an insider view on how his team is fundamentally changing and accelerating how new drug candidate molecules are designed, predicted, and optimized. Geared for students in computational sciences and hybrid STEM fields, the episode introduces listeners to uses of AI and ML in molecular design, the biomolecular structure and structure-function relationships that underpin drug discovery, and how distinct teams at Genentech work together through an integrated computational system. Richard and Jordan use the opportunity to touch on how advances in the molecule design domain can inspire and inform advances in computational pathology and laboratory medicine. Richard also delves into the critical role of Explainable AI (XAI), interpretability, and error estimation in the drug design-prototype-test cycle, and provides advice on domain knowledge and skills needed today by students interested in joining teams like his at Genentech and Roche.

Is this your show?

Claim this listing to keep it up to date, reach guests who want to pitch you, and manage bookings with Guestify.

Claim this listing

More Technology podcasts